Przemysław Juszczyński

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

Michael R. Green, Stefano Monti, Scott J. Rodig et al. · Blood · 2010 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +17

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

Michael R. Green, Scott J. Rodig, Przemysław Juszczyński et al. · Clinical Cancer Research · 2012 · 683 citations

Medicine, Immunology, Oncology +17

The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

Przemysław Juszczyński, Jing Ouyang, Stefano Monti et al. · Proceedings of the National Academy of Sciences · 2007 · 327 citations · Full text

Life Sciences, Immunology, Oncology +17

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Lin‐Feng Chen, Stefano Monti, Przemysław Juszczyński et al. · Blood · 2007 · 311 citations

Life Sciences, Oncology, Pharmacology +16

SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas

Lin‐Feng Chen, Stefano Monti, Przemysław Juszczyński et al. · Cancer Cell · 2013 · 174 citations · Full text

Life Sciences, Cell Biology, Oncology +13